Importer of Controlled Substances Application: Siegfried USA, LLC, 106584 [2024-31301]
Download as PDF
106584
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
DEA. This administrative process in no
way alters the legal effect of this
document upon publication in the
Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2024–31318 Filed 12–27–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1475]
Importer of Controlled Substances
Application: Siegfried USA, LLC
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Siegfried USA, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 29, 2025. Such
persons may also file a written request
for a hearing on the application on or
before January 29, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
SUMMARY:
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on November 20, 2024,
Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Controlled substance
Drug code
Phenylacetone .........................................................................................................................................................
Opium, Raw .............................................................................................................................................................
Poppy Straw Concentrate ........................................................................................................................................
The company plans to import the
listed controlled substances to
manufacture bulk Active
Pharmaceuticals Ingredients for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–31301 Filed 12–27–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Matthew Okeke, M.D.; Decision and
Order
On February 14, 2024, the Drug
Enforcement Administration (DEA or
Government) issued an Order to Show
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
Cause (OSC) to Matthew Okeke, M.D., of
Las Vegas, Nevada (Registrant). Request
for Final Agency Action (RFAA),
Exhibit (RFAAX) 1, at 1, 3. The OSC
proposed the revocation of Registrant’s
Certificate of Registration No.
FO4173845, alleging that Registrant’s
registration should be revoked because
Registrant is ‘‘currently without
authority to handle controlled
substances in Nevada, the state in which
[he is] registered with DEA.’’ Id. at 2
(citing 21 U.S.C. 824(a)(3)).
The OSC notified Registrant of his
right to file a written request for hearing,
and that if he failed to file such a
request, he would be deemed to have
waived his right to a hearing and be in
default. Id. (citing 21 CFR1301.43).
Here, Registrant did not request a
hearing. RFAA, at 2.1 ‘‘A default, unless
1 Based on the Government’s submissions in its
RFAA dated April 16, 2024, the Agency finds that
service of the OSC on Registrant was adequate. The
included declaration from a DEA Diversion
Investigator (DI) indicates that on February 26,
2024, the DI left a copy of the OSC at Registrant’s
registered address. RFAAX 2, at 2. On the same
date, the DI emailed a copy of the OSC to
Registrant’s registered email address and to
Registrant’s attorney. Id. at 2; see also id.,
Attachment C. On February 27, 2024, the OSC was
mailed to Registrant’s residential address, with
delivery confirmed on March 2, 2024. Id. at 2; see
PO 00000
Frm 00179
Fmt 4703
Sfmt 4703
8501
9600
9670
Schedule
II
II
II
excused, shall be deemed to constitute
a waiver of the registrant’s/applicant’s
right to a hearing and an admission of
the factual allegations of the [OSC].’’ 21
CFR 1301.43(e).
Further, ‘‘[i]n the event that a
registrant . . . is deemed to be in
default . . . DEA may then file a request
for final agency action with the
Administrator, along with a record to
support its request. In such
circumstances, the Administrator may
enter a default final order pursuant to
[21 CFR] § 1316.67.’’ Id. § 1301.43(f)(1).
Here, the Government has requested
also id., Attachments D–E. Finally, on February 28,
2024, the DI left another copy of the OSC at
Registrant’s residential address. Id. at 2–3. The
Agency finds that Registrant was successfully
served the OSC by email on February 26, 2024, as
the emails to Registrant’s registered email address
and to Registrant’s attorney were not returned as
undeliverable. Mohammed S. Aljanaby, M.D., 82 FR
34,552, 34,552 (2017) (finding that service by email
satisfies due process where the email is not
returned as undeliverable and other methods have
been unsuccessful). The Agency finds that the DI’s
efforts to serve Registrant by other means were
‘‘‘reasonably calculated, under all the
circumstances, to apprise [Registrant] of the
pendency of the action.’’’ Jones v. Flowers, 547 U.S.
220, 226 (2006) (quoting Mullane v. Central
Hanover Bank & Trust Co., 339 U.S. 306, 314
(1950)). Therefore, due process notice requirements
have been satisfied.
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Page 106584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31301]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1475]
Importer of Controlled Substances Application: Siegfried USA, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Siegfried USA, LLC has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
January 29, 2025. Such persons may also file a written request for a
hearing on the application on or before January 29, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on November 20, 2024, Siegfried USA, LLC, 33 Industrial
Park Road, Pennsville, New Jersey 08070, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Phenylacetone........................... 8501 II
Opium, Raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk Active Pharmaceuticals Ingredients for distribution to
its customers. No other activities for these drug codes are authorized
for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-31301 Filed 12-27-24; 8:45 am]
BILLING CODE P